Date: November 18, 2014Regeneron Pharmaceuticals Inc • February 12th, 2015 • Pharmaceutical preparations • New York
Credit Suisse Capital LLC (“CS”) and Regeneron Pharmaceuticals, Inc. (“Issuer”) are parties to a warrant transaction pursuant to a November 13, 2013 assignment by Credit Suisse International, an affiliate of Dealer, to CS of such warrant transaction. The warrant transaction is evidenced by the Master Terms and Conditions for Base Warrants Issued by Regeneron Pharmaceuticals, Inc. dated as of October 18, 2011, supplemented by the written confirmation dated as of October 18, 2011 (the “Confirmation”) and amended by the Amendment dated as of May 14, 2014. Terms used herein but are not otherwise defined shall have meanings assigned to them in the Warrant Confirmation.
RESTATED AMENDMENT AGREEMENTAmendment Agreement • February 12th, 2015 • Regeneron Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment Agreement (this “Amendment Agreement”) dated as of May 7, 2012, is by and between Regeneron Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of New York and having its principal office at 777 Old Saw Mill River Road, Tarrytown, New York 10591 (“Regeneron”), and Bayer Healthcare LLC, a limited liability company having a principal place of business at 511 Benedict Avenue, Tarrytown, NY 10591 (“Company”).
